Healthcare provider profile · identity verified

Mark Krasnoff, M.D.

Internal Medicine · SAINT LOUIS, MO · NPI 1821016064

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Rosuvastatin Calcium	Rosuvastatin Calcium	532	151
Amlodipine Besylate	Amlodipine Besylate	508	163
Atorvastatin Calcium	Atorvastatin Calcium	481	155
Levothyroxine Sodium	Levothyroxine Sodium	333	89
Losartan Potassium	Losartan Potassium	326	96
Metoprolol Succinate	Metoprolol Succinate	309	89
Pantoprazole Sodium	Pantoprazole Sodium	267	83
Eliquis	Apixaban	240	51
Furosemide	Furosemide	225	70
Tamsulosin Hcl	Tamsulosin Hcl	212	54
Gabapentin	Gabapentin	203	62
Lisinopril	Lisinopril	201	59
Metformin Hcl Er	Metformin Hcl	191	52
Ozempic	Semaglutide	190	39
Hydrochlorothiazide	Hydrochlorothiazide	189	58
Pravastatin Sodium	Pravastatin Sodium	181	54
Famotidine	Famotidine	179	57
Potassium Chloride	Potassium Chloride	176	60
Omeprazole	Omeprazole	163	50
Jardiance	Empagliflozin	158	34
Simvastatin	Simvastatin	138	44
Allopurinol	Allopurinol	136	36
Arexvy	Rsvpref3 Antigen/As01e/Pf	127	127
Tramadol Hcl	Tramadol Hcl	127	34
Duloxetine Hcl	Duloxetine Hcl	121	36
Fluticasone Propionate	Fluticasone Propionate	110	52
Finasteride	Finasteride	96	27
Spironolactone	Spironolactone	95	30
Metoprolol Tartrate	Metoprolol Tartrate	94	27
Atenolol	Atenolol	92	22
Albuterol Sulfate Hfa	Albuterol Sulfate	88	36
Metformin Hcl	Metformin Hcl	87	29
Donepezil Hcl	Donepezil Hcl	86	28
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	86	25
Carvedilol	Carvedilol	83	30
Alprazolam	Alprazolam	82	25
Escitalopram Oxalate	Escitalopram Oxalate	82	35
Trazodone Hcl	Trazodone Hcl	80	27
Fluoxetine Hcl	Fluoxetine Hcl	75	24
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	73	18
Montelukast Sodium	Montelukast Sodium	73	24
Prednisone	Prednisone	73	30
Pregabalin	Pregabalin	72	suppressed
Irbesartan	Irbesartan	71	20
Olmesartan Medoxomil	Olmesartan Medoxomil	69	20
Clopidogrel	Clopidogrel Bisulfate	68	22
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	67	21
Meloxicam	Meloxicam	67	25
Bupropion Xl	Bupropion Hcl	66	17
Mounjaro	Tirzepatide	66	20
Abrysvo	Rsv Vacc, Pref A And Pref B/Pf	65	65
Venlafaxine Hcl Er	Venlafaxine Hcl	64	19
Synthroid	Levothyroxine Sodium	62	13
Glimepiride	Glimepiride	59	17
Sertraline Hcl	Sertraline Hcl	58	21
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	58	20
Hydralazine Hcl	Hydralazine Hcl	55	17
Trulicity	Dulaglutide	55	11
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	54	23
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	53	13
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	51	25
Warfarin Sodium	Warfarin Sodium	50	17
Alendronate Sodium	Alendronate Sodium	49	14
Lorazepam	Lorazepam	49	18
Ezetimibe	Ezetimibe	48	18
Oxybutynin Chloride Er	Oxybutynin Chloride	47	14
Tizanidine Hcl	Tizanidine Hcl	46	24
Diclofenac Sodium	Diclofenac Sodium	44	24
Zolpidem Tartrate	Zolpidem Tartrate	44	16
Felodipine Er	Felodipine	43	12
Citalopram Hbr	Citalopram Hydrobromide	42	13
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	42	19
Vitamin D2	Ergocalciferol (Vitamin D2)	42	19
Myrbetriq	Mirabegron	41	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	41	25
Morphine Sulfate Er	Morphine Sulfate	40	suppressed
Oxycodone Hcl	Oxycodone Hcl	40	14
Isosorbide Mononitrate Er	Isosorbide Mononitrate	38	suppressed
Chlorthalidone	Chlorthalidone	35	11
Memantine Hcl	Memantine Hcl	35	11
Hydrocortisone	Hydrocortisone	34	11
Arnuity Ellipta	Fluticasone Furoate	33	suppressed
Clonazepam	Clonazepam	33	suppressed
Folic Acid	Folic Acid	33	suppressed
Mirtazapine	Mirtazapine	33	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	31	suppressed
Minoxidil	Minoxidil	27	suppressed
Ropinirole Hcl	Ropinirole Hcl	27	suppressed
Solifenacin Succinate	Solifenacin Succinate	27	11
Bumetanide	Bumetanide	26	suppressed
Celecoxib	Celecoxib	26	11
Oxybutynin Chloride	Oxybutynin Chloride	26	suppressed
Valacyclovir	Valacyclovir Hcl	26	11
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	25	21
Lovastatin	Lovastatin	24	suppressed
Propranolol Hcl	Propranolol Hcl	24	suppressed
Propranolol Hcl Er	Propranolol Hcl	24	suppressed
Buspirone Hcl	Buspirone Hcl	23	suppressed
Farxiga	Dapagliflozin Propanediol	23	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	22	suppressed
Januvia	Sitagliptin Phosphate	22	suppressed
Paroxetine Hcl	Paroxetine Hcl	22	suppressed
Temazepam	Temazepam	22	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	21	suppressed
Ammonium Lactate	Ammonium Lactate	21	suppressed
Clonidine Hcl	Clonidine Hcl	21	suppressed
Nifedipine Er	Nifedipine	21	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	21	20
Telmisartan	Telmisartan	21	suppressed
Brilinta	Ticagrelor	20	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	20	suppressed
Sildenafil Citrate	Sildenafil Citrate	20	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	20	13
Diazepam	Diazepam	19	suppressed
Famciclovir	Famciclovir	19	suppressed
Fluocinonide	Fluocinonide	19	11
Memantine Hcl Er	Memantine Hcl	19	suppressed
Aspirin-Dipyridamole Er	Aspirin/Dipyridamole	18	suppressed
Azelastine Hcl	Azelastine Hcl	18	suppressed
Klor-Con M10	Potassium Chloride	18	suppressed
Lansoprazole	Lansoprazole	18	suppressed
Tiadylt Er	Diltiazem Hcl	18	suppressed
Humalog Kwikpen U-100	Insulin Lispro	17	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	17	suppressed
Azithromycin	Azithromycin	16	12
Carbidopa-Levodopa	Carbidopa/Levodopa	16	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	16	14
Meclizine Hcl	Meclizine Hcl	16	16
Cephalexin	Cephalexin	15	11
Etodolac	Etodolac	15	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	15	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	15	12
Prazosin Hcl	Prazosin Hcl	15	suppressed
Primidone	Primidone	15	suppressed
Cevimeline Hcl	Cevimeline Hcl	14	suppressed
Glipizide Er	Glipizide	14	suppressed
Metronidazole	Metronidazole	14	suppressed
Olmesartan-Hydrochlorothiazide	Olmesartan/Hydrochlorothiazide	14	suppressed
Rybelsus	Semaglutide	14	suppressed
Terbinafine Hcl	Terbinafine Hcl	14	14
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	14	suppressed
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	14	suppressed
Wixela Inhub	Fluticasone Propion/Salmeterol	14	suppressed
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	13	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	13	suppressed
Estradiol	Estradiol	13	suppressed
Ramipril	Ramipril	13	suppressed
Ventolin Hfa	Albuterol Sulfate	13	suppressed
Xarelto	Rivaroxaban	13	suppressed
Baclofen	Baclofen	12	suppressed
Bupropion Hcl	Bupropion Hcl	12	suppressed
Colchicine	Colchicine	12	suppressed
Diphenoxylate-Atropine	Diphenoxylate Hcl/Atropine	12	suppressed
Ibuprofen	Ibuprofen	12	suppressed
Ipratropium Bromide	Ipratropium Bromide	12	suppressed
Mupirocin	Mupirocin	12	suppressed
Phenytoin Sodium Extended	Phenytoin Sodium Extended	12	suppressed
Raloxifene Hcl	Raloxifene Hcl	12	suppressed
Topiramate	Topiramate	12	suppressed
Diltiazem Hcl	Diltiazem Hcl	11	suppressed
Novolog Flexpen	Insulin Aspart	11	suppressed
Nystatin	Nystatin	11	suppressed
Ondansetron Odt	Ondansetron	11	suppressed
Silodosin	Silodosin	11	suppressed
Spiriva Respimat	Tiotropium Bromide	11	suppressed
Tymlos	Abaloparatide	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error